Antiplatelet Therapy for NeuroEndovascular Therapy Retrospective Surveillance (ATHENS)

Antiplatelet Therapy for NeuroEndovascular Therapy Retrospective Surveillance (ATHENS) - Antiplatelet Therapy for NeuroEndovascular Therapy Retrospective Surveillance (ATHENS)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039875

Enrollment

400

Registered

2020-03-19

Start date

2019-09-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral aneurysm, cerebral artery stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 endovascular treatment of cerebral aneurysm and cerebral artery stenosis, treated between 2014/11/1 to 2016/10/31 2 20 year old or more at treatment 3 receive anti platelet treatment 4 received platelet coagulation examination 5 complete 6 moths follow up

Exclusion criteria

Exclusion criteria: ineligible patient for study by investigator decision

Design outcomes

Primary

Measure	Time frame
schemic stroke during 15 months after endovascular treatment of intracranial aneurysm and cerebral artery stenosis	—

Secondary

Measure	Time frame
1 death and all stroke during 15 months after endovascular treatment of intracranial aneurysm and cerebral artery stenosis 2 hemorrhagic event during 15 months after endovascular treatment of intracranial aneurysm and cerebral artery stenosis	—

Countries

Japan

Contacts

Public ContactChiaki Sakai

Kobe City Medical Center General Hospital Center for Clinical Research and Innovation

chiakimk@cronos.ocn.ne.jp078-302-4321

Outcome results